bioMérieux SA, Abbott and Bruker are Dominating the Global Parasitology Identification Market in 2020

Global Parasitology Identification Market is expected to grow with the CAGR of 5.5% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-parasitology-identification-market

Global parasitology identification market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global parasitology identification market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in June 2019, Abbott Laboratories rings together Malaria no more and the government of Odisha, to fight the growing incidence of malaria in the state. Abbott Laboratories will be providing 1 Million rapid diagnosis kits, and technological experts to help the Odisha Government fight Malaria. This will speed up the diagnosis rate, helps in increasing the product portfolio and help to expand the market share.

bioMérieux SA is the dominating player in the parasitology identification market. The other key players existing in the market includes Abbott, Thermofisher Scientific Inc, Shimadzu Corporation, Bruker, BD, altona Diagnostics GmbH, Biomerica, Inc, Bio-Rad Laboratories, Inc, Creative Diagnostics, Liferiver Bio-Tech (United States) Corp, Luminex Corporation, Meridian Bioscience, Inc, ORGENTEC Diagnostika GmbH, R-Biopharm AG, Quest Diagnostics Incorporated, Tecan Trading AG, Trinity Biotech, Institut Virion \ Serion GmbH, VWR International, LLC (a subsidiary of Avantor, Inc.), among others.

Parasitology Identification MarketbioMérieux SA

bioMérieux SA was incorporated in 1963 and is headquartered in Marcy I’Etoile, France. The company is focused on pioneering spirits and unrelenting commitment to improve public healthcare worldwide. The company provides variety of products like PCR system and kits for the diagnosis of parasites.

  • In April 2016, bioMeriuex SA has got the FDA clearance of Biofire in the field of diagnostics for blood culture detection. The beneficial advantage is the quick product approval which will lead to rise in sales and increase in revenue. bioMeriuex SAhave increased their product portfolio after adding up of this new product.

The company has presence across North America, South America, Europe, Asia-Pacific, Middle East and Africa, Oceania.

Abbott

Abbott headquartered in Illinois, U.S. The company was incorporated in 1888. The company is focused on creating products in diagnostics, medical devices, nutrition and branded generic pharmaceuticals that help you, your family and your community lives healthier lives.

  • In July 2018, Abbott worked with Bill & Melinda Gates Foundation, PATH, and Foundation of new innovative diagnostics, and developed a new diagnostics test for malaria that can detect very low levels of the parasite in the human body. With this, the company has enhanced its offering in the market.

The company has wide presence across North America, South America, Europe, Asia-Pacific, Middle East and Africa.

Bruker

Bruker was founded in 1960 and is headquarter in Massachusetts, U.S.. The company is focused on to improve energy and resource efficiency, eco-friendliness throughout the entire life cycle of products, noise and emission reduction, safety, security and dependability.

  • In August 2018, Bruker announced the acquisition of German based company Hain life science GmbH. It’s a molecular diagnostic company. This will help in generating more revenue and Portfolio of the company and helped in serving more customers.

The company has wide presence across North America, Asia-Pacific, and Europe.